LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:LCAV
CUSIPN/A
Phone+1-513-7929292
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
LCA-Vision (NASDAQ:LCAV) Frequently Asked Questions
What is LCA-Vision's stock symbol?
LCA-Vision trades on the NASDAQ under the ticker symbol "LCAV."
How were LCA-Vision's earnings last quarter?
LCA-Vision Inc. (NASDAQ:LCAV) issued its earnings results on Wednesday, April, 30th. The healthcare company reported ($0.01) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.23 by $0.24. The healthcare company earned $25.53 million during the quarter, compared to analysts' expectations of $32.04 million. View LCA-Vision's Earnings History.
Has LCA-Vision been receiving favorable news coverage?
News headlines about LCAV stock have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LCA-Vision earned a media and rumor sentiment score of 0.03 on Accern's scale. They also assigned news articles about the healthcare company an impact score of 49.91 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View Recent Headlines for LCA-Vision.
How do I buy shares of LCA-Vision?
Shares of LCAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact LCA-Vision?
LCA-Vision's mailing address is 7840 Montgomery Rd, CINCINNATI, OH 45236-4301, United States. The healthcare company can be reached via phone at +1-513-7929292.
MarketBeat Community Rating for LCA-Vision (NASDAQ LCAV)
MarketBeat's community ratings are surveys of what our community members think about LCA-Vision and other stocks. Vote "Outperform" if you believe LCAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
